DNLI (DENALI THERAPEUTICS INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 5 institutional investors hold DNLI (DENALI THERAPEUTICS INC) with a combined value of $313.09M across 18,963,844 shares. The largest holder is BlackRock, Inc. with a position worth $209.93M (0.00% of their portfolio). 2 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$313.09M
Total Shares Held
18,963,844
Institutional Holders
5
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $209.93M | 0.00% | +3.5% |
| 2 | BAKER BROS. ADVISORS LP | $61.61M | 0.36% | - |
| 3 | Point72 Asset Management, L.P. | $28.07M | 0.03% | -32.5% |
| 4 | CITADEL ADVISORS LLC | $13.31M | 0.00% | +15.2% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $176.66K | 0.00% | -82.1% |